Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890812 · ClinicalTrials.gov registry record
Factor XI Levels in Acute Ischemic Stroke
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 450
- Enrollment target
NCT00890812 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 450 participants.
The verdict
NCT00890812 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the utility of measuring coagulation factor activities in the setting of acute ischemic stroke, as potential markers of inherited thrombotic risk. The investigators will determine if relationships exist between coagulation factors, including factor VIII, factor IX, and factor XI and clinical diagnosis, classification, and outcome. The investigators will determine if any significant elevations of these factor activities are independent thrombotic risk factors. Null Hypothesis: There is no statistical difference between coagulation factors, including factors VIII, IX, or XI activity levels in patients having acute ischemic stroke as compared to acute stroke mimics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00890812
The ClinicalTrials.gov registry entry for NCT00890812 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00890812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00890812 about?
NCT00890812 is a clinical study titled "Factor XI Levels in Acute Ischemic Stroke". The purpose of this study is to evaluate the utility of measuring coagulation factor activities in the setting of acute ischemic stroke, as potential markers of inherited thrombotic risk. The investigators will determine if relationships exist between coagulation factors, including factor VIII, fact...
What is the current status of trial NCT00890812?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2009-05. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00890812?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.